Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 4(2)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05359744Not ApplicableCompleted

Multi-level Molecular Profiling of Peak Performance in Endurance Sports

Role: collaborator

NCT00204061Phase 4Completed

Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis

Role: collaborator

NCT00204087Phase 3Unknown

Psychological Intervention for Persons in the Early Initial Prodromal State

Role: collaborator

NCT00157378Phase 4Unknown

Optimization of Acute Treatment in First Episode Schizophrenia

Role: collaborator

All 4 trials loaded